. /.   WORLD TRADE  
ORGANIZATION  G/SPS/N/KOR/342 
26 August 2009 
 (09-4028) 
Committee on Sanitary a nd Phytosanitary Measures Original:   English 
  
 
NOTIFICATION 
 
1. Notifying Member:  REPUBLIC OF KOREA
 
If applicable, name of local government involved:    
2. Agency responsible:  Korea Food and Drug Administration 
3. Products covered (provide tariff item numbe r(s) as specified in national schedules 
deposited with the WTO;  ICS numbers should be provided in addition, where 
applicable):  Health/Functional Foods 
4. Regions or countries likely to be affected, to the extent relevant or practicable: 
[X] All trading partners [ ] Specific regions or countries:    
5. Title of the notified document:  Proposed Revision of the Standards and Specifications for 
Health/Functional Foods  Language:  Korean  Number of pages:  35 
6. Description of content:  By means of this proposed revision, the following ingredients are 
allowed for use in health/functional food:  coenzyme Q10, soy isoflavone, garcinia 
cambogia extract, lutein, haematococcus extract, and saw palmetto fruit extract. 
The proposal contains revised standards and specifications for ginseng and red ginseng 
including the requirement that functional ingr edients be no less than 80 per cent of the 
content indicated on the label in end products. 
Cuttlebone is allowed to be used as raw material in N-acetylglucosamine. 
7. Objective and rationale:  [X] food safety, [ ] animal health, [ ] plant protection, 
[  ] protect humans from animal/plant pest or disease, [ ] protect territory from other 
damage from pests.    
8. Is there a relevant international stan dard?  If so, identify the standard:  
[ ] Codex Alimentarius Commission (e.g.  title or serial number of Codex standard 
or related text)   
[ ] World Organization for Animal Health (OIE) (e.g. Terrestrial or Aquatic 
Animal Health Code, chapter number)    
[ ] International Plant Protection Convention (e.g. ISPM number)    
[X] None 
Does this proposed regulation conform to the relevant international standard?   
 [ ] Yes   [ ] No G/SPS/N/KOR/342 
Page 2  
 
   If no, describe, whenever possible, how and why it deviates from the 
international standard:    
9. Other relevant documents and language (s) in which these are available:  Korea Food 
and Drug Administration Advance Notice No. 2009-229, 18 August 2009 (available in 
Korean) 
10. Proposed date of adoption (dd/mm/yy) :  To be determined. 
Proposed date of publication (dd/mm/yy) :  To be determined. 
11. Proposed date of entry into force:  [ ] Six months from date of publication , and/or  
(dd/mm/yy) :  To be determined. 
[ ] Trade facilitating measure 
12. Final date for comments:  [X] Sixty days  from the date of circulation of the 
notification and/or (dd/mm/yy) :  25 October 2009 
Agency or authority designated to handl e comments:  [ ] National Notification 
Authority, [X] National Enquiry Point.  Address, fax number and e-mail address (if 
available) of other body:   
International Trade & Statistics Office 
Korea Food and Drug Administration 
#194 Tongilro, Eunpyeong-gu 
Seoul, 122-704 Korea Tel:  +(82 2) 380 1661 Fax:  +(82 2) 356 2893 E-mail:  wtokfda@kfda.go.kr 
13. Texts available from:  [ ] National Notification  Authority, [X] National Enquiry Point.  
Address, fax number and e-mail address (if available) of other body:    
Documents are available from the Korea Food and Drug Administration website at 
http://www.kfda.go.kr .  Also available from:   
International Trade & Statistics Office 
Korea Food and Drug Administration #194 Tongilro, Eunpyeong-gu Seoul, 122-704 Korea 
Tel:  +(82 2) 380 1661 
Fax:  +(82 2) 356 2893 E-mail:  wtokfda@kfda.go.kr